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    The choice of anesthesia in patients with peripheral artery 
occlusive disease (PAOD) is often challenging for anesthesio-
logists and surgeons because most of these patients have 
coronary artery disease and/or other co-morbid diseases. Many 
such patients also take anticoagulation agents. Van Damme 
et al. [1] reported that the factors affecting postoperative 
mortality include chronic renal failure, hypertension, and 
myocardial infarction. Mangano [2] reported that 5-15% of 
all patients with PAOD also demonstrate perioperative acute 
myocardial infarction, with a postoperative mortality rate 
of 2-15%. In a retrospective study of 14,788 patients who 
underwent infrainguinal bypass, Singh et al. [3] observed that 
patients who received general anesthesia showed the highest 
rates of myocardial infarction, pulmonary complications and 
re-operation. Unfortunately, many patients with PAOD are 
prescribed anticoagulants which make it difficult to administer 
regional anesthesia. Monitored anesthesia care (MAC) with 
remifentanil through target-controlled infusion and local 
infiltration is a safe and useful alternative to general anesthesia 
for infrainguinal vascular surgery. In this report, we describe a 
patient who was treated by femoro-femoral bypass graft for a 
left common iliac artery occlusion under MAC. 
    A 70-year-old man 163 cm in height and 63 kg in weight was 
admitted to our institution due to severe resting pain in both 
legs. He had severe right coronary artery occlusive disease, 
which had been treated with the placement of a coronary 
stent 2 years prior. The patient was on a medication regimen 
of aspirin and clopidogrel. He exhibited severe stenosis of the 
left anterior descending and left circumflex coronary arteries 
on coronary CT, and hypokinesia of the anteroseptum and 
akinesia of the inferior wall on echocardiography. The patient 
also had a 3-year history of hypertension and diabetes. A 
femoral artery angiogram showed right external iliac artery 
stenosis and complete obstruction of the left common iliac 
artery (Fig. 1). A stent was inserted into the right iliac artery, 
but femoral-to-femoral bypass graft surgery was scheduled for 
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Fig. 1. Lower abdominal aortography shows non-visualization of 
left common iliac artery to left common femoral artery by complete 
obstruction (single arrow), stent state of right external iliac artery 
and non-visualization of right internal iliac artery by obstruction 
(double arrows). And enlargement of both lumbar arteries are also 
noted.170 www.ekja.org
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revascularization of the left common iliac artery. The placement 
of a coronary stent was delayed until after the femoral bypass 
graft due to intractable leg pain.
    The anesthesiologists explained the patient’s general 
condition, combined diseases, risks of anesthesia, and MAC 
method to the patient, his family members and the surgeon. 
All parties understood the circumstances and agreed to the 
performance of MAC.
    Upon arrival at the operating theater, the patient’s BP was 
120/70 mmHg, heart rate was 80 beat/min, and O2 saturation 
was 99% through a simple facial mask with 4 L/min of oxygen. 
Oxygen was administered continuously during surgery. 
We monitored direct arterial pressure, lead II and V5 EKG, 
bispectral index (BIS, Aspect
Ⓡ Medical Systems, Norwood, MA, 
USA), pulseoximetry, and end tidal CO2 via nasal cannula to 
assess the patient’s respiratory rate. Remifentanil was given at 
a dose 1.0 ng/ml of effect site concentration (EC) by infusion 
pump (Orchestra Base Primea
Ⓡ, Fresenius Vial, France) for 5 
minutes, and then increased first to 1.5 and then 2.0 ng/ml at 
5 minute intervals before local infiltration to minimize patient 
discomfort and respiratory depression. A 1% lidocaine and 
0.25% ropivacaine mixture (1 : 1, 20 ml) was infiltrated at both 
the inguinal incision site and the subcutaneous tunneling 
area. We increased the remifentanil EC to 2.5-3.5 ng/ml when 
painful surgical stimulation occurred, such as femoral artery 
dissection, subcutaneous tunneling and vascular clamping. 
When the stimulation ended, the EC was readjusted. We 
administered isosorbid dinitrate 0.5 μg/kg at the time we started 
the MAC. 
    We were prepared to decrease the remifentanil EC to 0.3 
ng/ml immediately if the patient experienced respiratory 
depression (less than 7 breaths/min or more than 15 seconds 
of apnea). Fortunately, no special events such as hypotension, 
tarchycardia, cardiac events, patient complaints, respiratory 
depression, or apnea occurred during the procedure. When the 
remifentanil EC was 3.5 ng/ml, the patient’s respiratory rate was 
10 breaths/min. When necessary, we encouraged the patient 
to take a deep breath, allowing him to be ventilated sufficiently 
without requiring assisted ventilation.
    During the operation, the EC range of remifentanil was 2.0-
3.5 ng/ml, the BIS score was greater than 90, and the modified 
observer assessment of the patient alertness/sedation score 
was 5 (indicating that the patient was able to promptly open his 
eyes when an observer whispered his name). The patient stated 
that he did not feel discomfort or anxiety. He was discharged 
on postoperative day 4 without any complications, and 1 week 
after discharge he underwent coronary stent insertion without 
incident.
    MAC is usually performed with short acting hypnotics and 
opioids, which provide excellent anxiolytic and analgesic 
effects. However, the use of combined hypnotics and opioids 
may result in respiratory depression, apnea and hypoxia 
even in healthy volunteers [4]. For this reason, we used only 
remifentanil in our patient, and increased EC as slowly as 
possible to prevent hypotension, hypercapnea, or hypoxia from 
occurring due to respiratory depression. The EC of remifentanil 
is easily controlled for each level of surgical pain because it 
has a short context-sensitive half life, does not accumulate 
and provides rapid, predictable analgesia. Remifentanil is not 
usually used alone, but when previously used in fiber optic 
bronchoscopic awake intubation, it yielded excellent patient 
cooperation and comfort within the 2.4 ± 0.8 ng/ml range [5]. 
The choice of anesthesia is complex in patients with PAOD, who 
usually combine coronary artery disease conditions demanding 
treatment by coronary stent with other complications such as 
hypertension, diabetes, and antiplatelet medications, like our 
patient. Surgeons are also often required to provide complex 
postoperative care for such patients. We decided to use MAC for 
our patient due to its many advantages over general or regional 
anesthesia. First, MAC allows clinicians to avoid intubation 
and hemodynamic instability, and is free from the risks of 
spinal hematoma and hypotension, urinary retention, and 
many other complications. Hemodynamic stability is essential 
to the management of coronary patients, and may also avoid 
pulmonary complications. 
    In conclusion, surgery was performed successfully under 
MAC without the occurrence of respiratory depression or 
cardiac events in our patient, who tolerated the procedure well 
and was satisfied with the anesthesia.
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